Immucell (ICCC) EBITDA Margin (QoQ) (2010 - 2025)
Analysis
Immucell (ICCC) EBITDA Margin (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 39.99 Bn | 39.79 Bn | 779.09 Mn |
| 2 | Zoetis | 30.50 Bn | 28.83 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.44 Bn | 10.91 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.34 Mn | 67.24 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -112.00 |
| Sep 30, 2025 | -847.00 |
| Jun 30, 2025 | -502.00 |
| Mar 31, 2025 | 584.00 |
| Dec 31, 2024 | 1,758.00 |
| Sep 30, 2024 | 1,577.00 |
| Jun 30, 2024 | -2,120.00 |
| Sep 30, 2023 | 1,499.00 |
| Jun 30, 2023 | 2,853.00 |
| Mar 31, 2023 | -2,368.00 |
| Dec 31, 2022 | -2,891.00 |
| Sep 30, 2022 | 317.00 |
| Jun 30, 2022 | -2,554.00 |
| Mar 31, 2022 | 684.00 |
| Dec 31, 2021 | -259.00 |
| Sep 30, 2021 | 52.00 |
| Jun 30, 2021 | 1,387.00 |
| Mar 31, 2021 | 783.00 |
| Dec 31, 2020 | -1,019.00 |
| Sep 30, 2020 | 1,655.00 |